Article Details
Retrieved on: 2024-11-13 20:10:00
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article explores advancements and challenges in CAR-T therapy, emphasizing product strategy at Sino Biological in the cancer immunotherapy landscape. It discusses targeting the immune system, tumor microenvironments, and immune checkpoints like PD-L1.
Article found on: www.biotechniques.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here